Case of the week 29/2019


Use of CytoSorb in a patient with infective endocarditis-associated refractory septic shock and acute kidney injury
Cianciotta F1, Iacobellis MA1, Campobasso N1, Rubino G2, Milano AD2, Gesualdo L1, Pertosa GB1 | 1Department of Emergency and Organ Transplantation (DETO), Nephrology, Dialysis and Transplantation Unit, University of Bari | 2Cardiac Surgery Unit, University of Bari | Purification Therapies Workshop – The ideas for clinical research. Milan, Italy March 15 – 16 2019

This report describes the case of a 45-year-old man with a ventriculo-peritoneal (VP) shunt due to neonatal hydrocephalus, who was admitted to the hospital with suspected septic shock.


The Therapy

An extracorporeal blood purification therapy to reduce excessive inflammation mediators

The Fields of Application

Treat septic shock & severe sepsis on ICU, prevent SIRS in cardiac surgery patients

The Studies

Current multi- and monocentric study projects in Europe and US, an international registry, case series

The Adsorber

A cutting edge bead technology turns CytoSorb into the only specifically approved extracorporeal cytokine adsorber

CytoSorb registry

Become part of the International CytoSorb registry!

For the first time treatment data, courses of treatment and results of a new treatment are systematically recorded according to highest scientific standards.